Younger patients with a specific form of myositis associated with antibodies to a protein called HMGCR have a worse prognosis than older patients.
The older the better, when it comes to anti-HMGCR associated myositis
News
Pneumocystis jiroveci pneumonia is a rare but serious complication for patients with rheumatic diseases
Medical record review of patients admitted to the Johns Hopkins Hospital over 20-years, revealed that pneumocystis jiroveci pneumonia infection is a rare but persistent risk for patients with rheumatic diseases.
Joint Injections 101
Dr. Myma Albayda with the Johns Hopkins Arthritis Center highlights what’s involved in a joint injection.
LEAP: Winter 2017
In this issue of LEAP you can read about our precision approach to an increasingly common illness, gout, to a rare illness linked to Sjögren’s, and to cancer patients who are developing some autoimmune-mediated complications. And we are especially excited to share with you a tremendous breakthrough in understanding how rheumatoid arthritis begins.
Gum disease linked to rheumatoid arthritis
The study provides new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory autoimmune response characteristic of chronic, joint-destroying rheumatoid arthritis (RA). The new findings have important implications for prevention and treatment of RA.
Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer
A new biomarker discovered using cutting-edge technologies is found in people who develop scleroderma and cancer within a short period of time.
